C1 Inhibitor (C1-INH) stands as a sentinel in immune regulation, orchestrating the delicate balance of our body’s defense mechanisms. As a master suppressor, C1-INH targets key enzymes across various immune pathways, safeguarding against unwarranted inflammation and preserving vascular stability. Its distinctive function in conserving the Alternative Pathway, while meticulously regulating the Classical and Lectin pathways, marks it as an integral component in immune homeostasis. In the clinical realm, C1-INH is pivotal in managing hereditary angioedema (HAE)—a condition marked by sudden, intense swelling. As a diagnostic marker, C1-INH is gaining recognition for its potential to detect early signs of MIS-C, SLE, and MS, heralding a new era in the proactive management of these complex conditions.
This product is manufactured in Netherlands by Hycult Biotech.
Size | 1 x 96 Well |
Sensitivity | 3.9 ng/mL |
Dynamic Range | 3.9 – 250 ng/mL |
Incubation Time | 1 hour 15 minutes |
Sample Type | Serum, Plasma |
Immunogen | |
Source Species | |
Specificity | |
Expression System | |
Clone | |
Group | |
Alpha Chain | |
Beta Chain | |
Peptide | |
Peptide Source | |
Format | |
Buffer | |
Concentration | |
Storage | 2-8°C |
Alternative Names | C1 Inhibitor |
Instructions For Use | https://eaglebio.com/wp-content/uploads/2025/03/HK396_C1-INH_ELISA_Kit_Package_Insert.pdf |
MSDS | https://eaglebio.com/wp-content/uploads/2025/03/HK396_C1-INH_ELISA_Kit_SDS.pdf |